FIELD: medicine; hepatology; infectious diseases; oncology.
SUBSTANCE: invention can be used to predict relapse of hepatitis D after completion of antiviral therapy. Hepatitis D virus RNA is determined in the patient's hepatobiopsy using the polymerase chain reaction (PCR). If a positive PCR result for hepatitis D virus RNA is obtained in a hepatobiopsy and there is a negative PCR result for hepatitis D virus RNA in the blood serum, a relapse of hepatitis D is predicted within 4–24 weeks after the end of treatment.
EFFECT: method improves the accuracy of predicting relapse of hepatitis D after completion of antiviral therapy due to the early detection of hepatitis D virus RNA in hepatobiopsy material.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING CHRONIC VIRAL HEPATITIS C | 2011 |
|
RU2459629C1 |
| METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
| METHOD FOR PREDICTION OF EFFICACY OF ANTIVIRAL TREATMENT OF CHRONIC VIRAL HEPATITIS C | 2013 |
|
RU2546032C2 |
| METHOD FOR PREDICTION OF EFFICACY OF ANTIVIRAL THERAPY IN ADULT PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1b | 2012 |
|
RU2522500C1 |
| METHOD FOR PREDICTING EFFICIENCY OF INTERFERONOTHERAPY AT CHRONIC HEPATITIS B | 2005 |
|
RU2287826C1 |
| METHOD FOR PREDICTING THE RESULTS OF TREATING PATIENTS WITH CHRONIC HEPATITIS C WITH INTERFERON-ALPHA PREPARATIONS | 2005 |
|
RU2287825C1 |
| METHOD FOR INDIVIDUAL PREDICTION OF THERAPEUTIC EFFICACY OF CHRONIC HEPATITIS C WITH PEGYLATED INTERFERON ALPHA AND RIBAVIRIN | 2013 |
|
RU2525159C1 |
| METHOD FOR PREDICTING THE ABSENCE OF REGRESS OF HEPATIC FIBROSIS IN THE PATIENTS WITH CHRONIC HEPATITIS C | 2019 |
|
RU2723387C1 |
| METHOD FOR PREDICTION OF FORMATION OF VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2461834C1 |
| METHOD FOR PREDICTION OF IF THERAPY EFFECTIVENESS FOR VIRAL HEPATITIS IN CHILDREN | 2008 |
|
RU2379689C1 |
